Shenzhen Neptunus Bioengineering Co., Ltd. (SHE:000078)
China · Delayed Price · Currency is CNY 1.330
+0.020 (1.53%)
Oct 23, 2026, 3:04 PM CST
SHE:000078 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 23,655 | 26,668 | 30,317 | 36,419 | 37,835 | 41,054 |
Revenue Growth | -15.51% | -12.04% | -16.75% | -3.74% | -7.84% | 2.58% |
Gross Profit Gross Profit Growth | 2,175 | 2,469 | 2,832 | 3,518 | 3,776 | 4,394 |
Operating Income Operating Income Growth | 43.36 | 254.72 | 176.9 | 618.73 | 764.95 | 1,460 |
Net Income Net Income Growth | -798.69 | -563.06 | -1,193 | -1,690 | -1,027 | 93.3 |
Earnings Per Share EPS Growth | -0.30 | -0.21 | -0.45 | -0.64 | -0.39 | 0.04 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Distribution Pharmaceutical Distribution Growth | 14,016 | 16,486 | 20,057 | 23,566 | 27,044 | 30,426 |
Pharmaceutical Manufacturing Pharmaceutical Manufacturing Growth | 385.73 | 429.71 | 445.79 | 473.12 | 503.01 | 416.31 |
Health Products, Food Health Products, Food Growth | 149.26 | 141.7 | 123.49 | 92.02 | 127.12 | 193.99 |
Medical Instruments Medical Instruments Growth | 9,068 | 9,555 | 9,588 | 12,179 | 10,085 | 9,890 |
Unallocated Other Unallocated Other Growth | 36.63 | 55.39 | 102.93 | 108.77 | 76.08 | 127.23 |
Total Total Growth | 23,655 | 26,668 | 30,317 | 36,419 | 37,835 | 41,054 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 2,412 | 3,098 | 3,603 | 3,898 | 3,702 | 4,162 |
Total Debt Total Debt Growth | 10,187 | 11,702 | 10,578 | 11,401 | 11,922 | 12,580 |
Net Cash (Debt) Net Cash Growth | -7,775 | -8,604 | -6,975 | -7,502 | -8,220 | -8,418 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -2.96 | -3.27 | -2.65 | -2.85 | -3.13 | -3.20 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 81.92 | 104.39 | 39.54 | -410.19 | -64.33 | 866.12 |
Capital Expenditures CapEx Growth | -72.43 | -127.09 | -84.6 | -104.07 | -94.32 | -129.23 |
Free Cash Flow Free Cash Flow Growth | 9.49 | -22.7 | -45.06 | -514.26 | -158.65 | 736.89 |
Free Cash Flow Growth | - | - | - | - | - | -50.98% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 9.20% | 9.26% | 9.34% | 9.66% | 9.98% | 10.70% |
Operating Margin | 0.18% | 0.95% | 0.58% | 1.70% | 2.02% | 3.56% |
Pretax Margin | -3.41% | -1.87% | -3.57% | -4.00% | -2.25% | 1.40% |
Profit Margin | -3.38% | -2.11% | -3.94% | -4.64% | -2.71% | 0.23% |
FCF Margin | 0.04% | -0.08% | -0.15% | -1.41% | -0.42% | 1.80% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | - | - | - | 104.08 |
Forward PE | - | 18.08 | 18.08 | 18.08 | 18.08 | 18.08 |
P/FCF Ratio | 368.66 | - | - | - | - | 13.18 |
PS Ratio | 0.15 | 0.34 | 0.22 | 0.24 | 0.24 | 0.24 |